These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28583636)

  • 1. Metabolic profile of liver damage in non-cirrhotic virus C and autoimmune hepatitis: A proton decoupled
    Hakkarainen A; Puustinen L; Kivisaari R; Boyd S; Nieminen U; Arkkila P; Lundbom N
    Eur J Radiol; 2017 May; 90():205-211. PubMed ID: 28583636
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Puustinen L; Hakkarainen A; Kivisaari R; Boyd S; Nieminen U; Färkkilä M; Lundbom N; Arkkila P
    Scand J Gastroenterol; 2017 Aug; 52(8):886-892. PubMed ID: 28415898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonalcoholic fatty liver disease: detection of elevated nicotinamide adenine dinucleotide phosphate with in vivo 3.0-T 31P MR spectroscopy with proton decoupling.
    Sevastianova K; Hakkarainen A; Kotronen A; Cornér A; Arkkila P; Arola J; Westerbacka J; Bergholm R; Lundbom J; Lundbom N; Yki-Järvinen H
    Radiology; 2010 Aug; 256(2):466-73. PubMed ID: 20656836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-alcoholic fatty liver disease: spectral patterns observed from an in vivo phosphorus magnetic resonance spectroscopy study.
    Abrigo JM; Shen J; Wong VW; Yeung DK; Wong GL; Chim AM; Chan AW; Choi PC; Chan FK; Chan HL; Chu WC
    J Hepatol; 2014 Apr; 60(4):809-15. PubMed ID: 24291241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High resolution in vivo 31P-MRS of the liver: potential advantages in the assessment of non-alcoholic fatty liver disease.
    Jeon MJ; Lee Y; Ahn S; Lee C; Kim OH; Oh BC; Yu U; Kim H
    Acta Radiol; 2015 Sep; 56(9):1051-60. PubMed ID: 25270373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultra-high-field magnetic resonance spectroscopy in non-alcoholic fatty liver disease: Novel mechanistic and diagnostic insights of energy metabolism in non-alcoholic steatohepatitis and advanced fibrosis.
    Traussnigg S; Kienbacher C; Gajdošík M; Valkovič L; Halilbasic E; Stift J; Rechling C; Hofer H; Steindl-Munda P; Ferenci P; Wrba F; Trattnig S; Krššák M; Trauner M
    Liver Int; 2017 Oct; 37(10):1544-1553. PubMed ID: 28544208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic phospholipids in alcoholic liver disease assessed by proton-decoupled 31P magnetic resonance spectroscopy.
    Schlemmer HP; Sawatzki T; Sammet S; Dornacher I; Bachert P; van Kaick G; Waldherr R; Seitz HK
    J Hepatol; 2005 May; 42(5):752-9. PubMed ID: 15826726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of 31P MR spectroscopy to the histopathological grading of chronic hepatitis and response to therapy.
    Kiyono K; Shibata A; Sone S; Watanabe T; Oguchi M; Shikama N; Ichijo T; Kiyosawa K; Sodeyama T
    Acta Radiol; 1998 May; 39(3):309-14. PubMed ID: 9571950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo and in vitro hepatic phosphorus-31 magnetic resonance spectroscopy and electron microscopy in chronic ductopenic rejection of human liver allografts.
    Taylor-Robinson SD; Sargentoni J; Bell JD; Thomas EL; Marcus CD; Changani KK; Saeed N; Hodgson HJ; Davidson BR; Burroughs AK; Rolles K; Foster CS; Cox IJ
    Gut; 1998 May; 42(5):735-43. PubMed ID: 9659173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorus magnetic resonance spectroscopy in malformations of cortical development.
    Andrade CS; Otaduy MC; Valente KD; Maia DF; Park EJ; Valério RM; Tsunemi MH; Leite CC
    Epilepsia; 2011 Dec; 52(12):2276-84. PubMed ID: 21973076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EVALUATION OF ANTIVIRAL THERAPY TREATMENT FOR LIVER CIRRHOSIS CAUSED BY CHRONIC HEPATITIS C AND HEPATITIS C BY 31P-MRS, BASED ON METABOLITE DETECTION.
    Gu JS; Sun RR; Shen S; Yu ZJ
    J Biol Regul Homeost Agents; 2015; 29(2):443-50. PubMed ID: 26122235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early detection of changes in phospholipid metabolism during neoadjuvant chemotherapy in breast cancer patients using phosphorus magnetic resonance spectroscopy at 7T.
    Krikken E; van der Kemp WJM; van Diest PJ; van Dalen T; van Laarhoven HWM; Luijten PR; Klomp DWJ; Wijnen JP
    NMR Biomed; 2019 Jun; 32(6):e4086. PubMed ID: 30924571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered phospholipid metabolism in schizophrenia: a phosphorus 31 nuclear magnetic resonance spectroscopy study.
    Weber-Fahr W; Englisch S; Esser A; Tunc-Skarka N; Meyer-Lindenberg A; Ende G; Zink M
    Psychiatry Res; 2013 Dec; 214(3):365-73. PubMed ID: 24045051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of 31P magnetic resonance spectroscopy and microbubble-enhanced ultrasound for characterizing hepatitis c-related liver disease.
    Lim AK; Patel N; Eckersley RJ; Fitzpatrick J; Crossey MM; Hamilton G; Goldin RD; Thomas HC; Vennart W; Cosgrove DO; Taylor-Robinson SD
    J Viral Hepat; 2011 Oct; 18(10):e530-4. PubMed ID: 21914073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The relationship between 31P magnetic resonance spectroscopy and the histopathology of livers of chronic viral hepatitis patients].
    Wu B; Song B; Zhou XP; Yang Y; Lei XZ; Jiang LL
    Zhonghua Gan Zang Bing Za Zhi; 2007 May; 15(5):338-41. PubMed ID: 17524264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: biochemical basis of spectral appearances.
    Menon DK; Sargentoni J; Taylor-Robinson SD; Bell JD; Cox IJ; Bryant DJ; Coutts GA; Rolles K; Burroughs AK; Morgan MY
    Hepatology; 1995 Feb; 21(2):417-27. PubMed ID: 7843715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo and in vitro 31P magnetic resonance spectroscopy of focal hepatic malignancies.
    Cox IJ; Bell JD; Peden CJ; Iles RA; Foster CS; Watanapa P; Williamson RC
    NMR Biomed; 1992; 5(3):114-20. PubMed ID: 1322688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of biochemical metabolites by 31P MR spectroscopy in leukemic infiltration of liver].
    Sun JZ; Wang ZK; Yu RS; Huang LS; Xu XF; Zhang MM
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2010 Mar; 39(2):150-6. PubMed ID: 20387242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of Liver Inflammation on Liver Stiffness Measurement in Patients with Autoimmune Hepatitis Evaluation by Combinational Elastography.
    Yada N; Sakurai T; Minami T; Arizumi T; Takita M; Hagiwara S; Ida H; Ueshima K; Nishida N; Kudo M
    Oncology; 2017; 92 Suppl 1():10-15. PubMed ID: 28056459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorus-31 magnetic resonance spectroscopy of the human liver using chemical shift imaging techniques.
    Cox IJ; Menon DK; Sargentoni J; Bryant DJ; Collins AG; Coutts GA; Iles RA; Bell JD; Benjamin IS; Gilbey S
    J Hepatol; 1992 Mar; 14(2-3):265-75. PubMed ID: 1323598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.